Amidst a surge in influenza cases-particularly among children-French health authorities have extended the nation’s annual flu vaccination campaign through February 28th. The decision reflects growing concern over a new wave of the virus impacting both younger and older populations, and comes as hospitals brace for increased admissions [[1]]. While vaccination rates are up slightly from last year, health officials emphasize continued efforts are needed to protect vulnerable individuals and prevent further strain on the healthcare system.
French health authorities have extended the influenza vaccination campaign through February 28.
The decision comes as officials attempt to mitigate a new wave of influenza that could impact both adults and seniors, following a significant increase in cases among children under 15, according to French news outlet Midi Libre.
France’s Public Health Agency reports that influenza viruses continue to circulate actively, and the rise in pediatric cases in urban areas may lead to increased medical consultations and hospitalizations in the coming weeks. Influenza can be particularly dangerous for vulnerable populations, making vaccination efforts crucial for protecting public health.
A statement from the Directorate-General of Health indicated that the worsening epidemiological situation could disproportionately affect those at higher risk. More than half of intensive care admissions are currently patients aged 65 or older, and many of these individuals have not yet received a flu vaccine. Approximately three-quarters of patients whose vaccination status was known had not been vaccinated against influenza, while the number of deaths associated with the virus is comparable to levels seen at the peak of the previous season.
While vaccination coverage has improved compared to last season – reaching 46.3% of the targeted population and 53.3% among seniors – it remains insufficient to curb the virus’s spread. Preliminary estimates suggest this year’s vaccine effectiveness is around 36.5%, which still offers benefits in reducing complications associated with influenza, especially given the significant divergence of the currently circulating subtype K compared to the A (H3N2) strain included in this winter’s vaccine. The findings could inform future vaccine development and strain selection.
aXA6IDI0MDM6NmI4MDo4OjEwMDo6Njc3MzphNzUg جزيرة ام اند امز
